APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nanotechnology-based Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nanotechnology-based Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17419550034 March 2026185 pages

Choose your research edition.

Industry ResearchNanotechnology-based Drug Delivery Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanotechnology-based Drug Delivery Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Nanotechnology-based Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanotechnology-based Drug Delivery Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanotechnology-based Drug Delivery Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Nanotechnology-based Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nanotechnology-based Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nanotechnology-based Drug Delivery include AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, EyePoint Pharmaceuticals and Johnson and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nanotechnology-based Drug Delivery market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nanotechnology-based Drug Delivery and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nanotechnology-based Drug Delivery revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nanotechnology-based Drug Delivery market size, projected growth trends, production technologies, key applications, and end-use industries.

Nanotechnology-based Drug Delivery Segment by Company

AbbVie Inc.

BlueWillow Biologics Inc.

Camurus AB

Celgene, lnc.

Cristal Therapeutics

EyePoint Pharmaceuticals

Johnson and Johnson

Nanotechnology-based Drug Delivery Segment by Type

Nanocrystals

Nanoparticles

Liposomes

Micelles

Others

Nanotechnology-based Drug Delivery Segment by Application

Hospital

Research Institute

Others

Nanotechnology-based Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanotechnology-based Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanotechnology-based Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanotechnology-based Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nanotechnology-based Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanotechnology-based Drug Delivery industry.

Chapter 3: Detailed analysis of Nanotechnology-based Drug Delivery companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanotechnology-based Drug Deliveryrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Nanocrystals Table 3. Key Players of Nanoparticles Table 4. Key Players of Liposomes Table 3. Key Players of Micelles Table 4. Key Players of Others Table 5. Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Research Institute Table 8. Key Players of Others Table 9. Global Nanotechnology-based Drug Delivery Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Nanotechnology-based Drug Delivery Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Nanotechnology-based Drug Delivery Market Share by Region (2021-2026) Table 12. Global Nanotechnology-based Drug Delivery Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Nanotechnology-based Drug Delivery Market Share by Region (2027-2032) Table 14. Nanotechnology-based Drug Delivery Industry Trends Table 15. Nanotechnology-based Drug Delivery Industry Drivers Table 16. Nanotechnology-based Drug Delivery Industry Opportunities and Challenges Table 17. Nanotechnology-based Drug Delivery Industry Restraints Table 18. Global Nanotechnology-based Drug Delivery Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Nanotechnology-based Drug Delivery Revenue Market Share by Company (2021-2026) Table 20. Global Nanotechnology-based Drug Delivery Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nanotechnology-based Drug Delivery Key Company Head Office and Area Served Table 22. Global Nanotechnology-based Drug Delivery Company, Product Type & Application Table 23. Global Nanotechnology-based Drug Delivery Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Nanotechnology-based Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Nanotechnology-based Drug Delivery Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Nanotechnology-based Drug Delivery Revenue Market Share by Type (2021-2026) Table 30. Global Nanotechnology-based Drug Delivery Revenue Market Share by Type (2027-2032) Table 31. Global Nanotechnology-based Drug Delivery Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Nanotechnology-based Drug Delivery Revenue Market Share by Application (2021-2026) Table 35. Global Nanotechnology-based Drug Delivery Revenue Market Share by Application (2027-2032) Table 36. AbbVie Inc. Company Information Table 37. AbbVie Inc. Business Overview Table 38. AbbVie Inc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. AbbVie Inc. Nanotechnology-based Drug Delivery Product Portfolio Table 40. AbbVie Inc. Recent Development Table 41. BlueWillow Biologics Inc. Company Information Table 42. BlueWillow Biologics Inc. Business Overview Table 43. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product Portfolio Table 45. BlueWillow Biologics Inc. Recent Development Table 46. Camurus AB Company Information Table 47. Camurus AB Business Overview Table 48. Camurus AB Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Camurus AB Nanotechnology-based Drug Delivery Product Portfolio Table 50. Camurus AB Recent Development Table 51. Celgene, lnc. Company Information Table 52. Celgene, lnc. Business Overview Table 53. Celgene, lnc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Celgene, lnc. Nanotechnology-based Drug Delivery Product Portfolio Table 55. Celgene, lnc. Recent Development Table 56. Cristal Therapeutics Company Information Table 57. Cristal Therapeutics Business Overview Table 58. Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Cristal Therapeutics Nanotechnology-based Drug Delivery Product Portfolio Table 60. Cristal Therapeutics Recent Development Table 61. EyePoint Pharmaceuticals Company Information Table 62. EyePoint Pharmaceuticals Business Overview Table 63. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product Portfolio Table 65. EyePoint Pharmaceuticals Recent Development Table 66. Johnson and Johnson Company Information Table 67. Johnson and Johnson Business Overview Table 68. Johnson and Johnson Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Johnson and Johnson Nanotechnology-based Drug Delivery Product Portfolio Table 70. Johnson and Johnson Recent Development Table 71. North America Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 72. North America Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 73. North America Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 74. North America Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 75. North America Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026) Table 77. North America Nanotechnology-based Drug Delivery Market Size by Country (2027-2032) Table 78. Europe Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 79. Europe Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 80. Europe Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 81. Europe Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 82. Europe Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe Nanotechnology-based Drug Delivery Market Size by Country (2021-2026) Table 84. Europe Nanotechnology-based Drug Delivery Market Size by Country (2027-2032) Table 85. China Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 86. China Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 87. China Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 88. China Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 89. Asia Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 90. Asia Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 91. Asia Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 92. Asia Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia Nanotechnology-based Drug Delivery Market Size by Country (2021-2026) Table 95. Asia Nanotechnology-based Drug Delivery Market Size by Country (2027-2032) Table 96. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type (2021-2026) & (US$ Million) Table 97. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type (2027-2032) & (US$ Million) Table 98. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021-2026) Table 102. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Nanotechnology-based Drug Delivery Product Image Figure 2. Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nanotechnology-based Drug Delivery Market Share by Type: 2025 VS 2032 Figure 4. Nanocrystals Image Figure 5. Nanoparticles Image Figure 6. Liposomes Image Figure 7. Micelles Image Figure 8. Others Image Figure 9. Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Nanotechnology-based Drug Delivery Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Research Institute Image Figure 13. Others Image Figure 14. Global Nanotechnology-based Drug Delivery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 16. Global Nanotechnology-based Drug Delivery Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nanotechnology-based Drug Delivery Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nanotechnology-based Drug Delivery Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nanotechnology-based Drug Delivery Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nanotechnology-based Drug Delivery Revenue Market Share by Type (2021-2032) Figure 23. Global Nanotechnology-based Drug Delivery Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nanotechnology-based Drug Delivery Revenue Market Share by Application (2021-2032) Figure 25. North America Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 26. North America Nanotechnology-based Drug Delivery Market Share by Type (2021-2032) Figure 27. North America Nanotechnology-based Drug Delivery Market Share by Application (2021-2032) Figure 28. North America Nanotechnology-based Drug Delivery Market Share by Country (2021-2032) Figure 29. United States Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nanotechnology-based Drug Delivery Market Share by Type (2021-2032) Figure 34. Europe Nanotechnology-based Drug Delivery Market Share by Application (2021-2032) Figure 35. Europe Nanotechnology-based Drug Delivery Market Share by Country (2021-2032) Figure 36. Germany Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 37. France Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 42. China Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 43. China Nanotechnology-based Drug Delivery Market Share by Type (2021-2032) Figure 44. China Nanotechnology-based Drug Delivery Market Share by Application (2021-2032) Figure 45. Asia Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nanotechnology-based Drug Delivery Market Share by Type (2021-2032) Figure 47. Asia Nanotechnology-based Drug Delivery Market Share by Application (2021-2032) Figure 48. Asia Nanotechnology-based Drug Delivery Market Share by Country (2021-2032) Figure 49. Japan Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 53. India Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Country (2021-2032) Figure 59. Brazil Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nanotechnology-based Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Nanocrystals
  • Nanoparticles
  • Liposomes
  • Micelles
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • AbbVie Inc.
  • BlueWillow Biologics Inc.
  • Camurus AB
  • Celgene, lnc.
  • Cristal Therapeutics
  • EyePoint Pharmaceuticals
  • Johnson and Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Nanocrystals
  5. 1.2.3 Nanoparticles
  6. 1.2.4 Liposomes
  7. 1.2.5 Micelles
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Nanotechnology-based Drug Delivery Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Research Institute
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nanotechnology-based Drug Delivery Growth Trends by Region
  16. 1.5.1 Global Nanotechnology-based Drug Delivery Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nanotechnology-based Drug Delivery Market Size by Region (2021-2026)
  18. 1.5.3 Nanotechnology-based Drug Delivery Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nanotechnology-based Drug Delivery Market Dynamics
  1. 2.1 Nanotechnology-based Drug Delivery Industry Trends
  2. 2.2 Nanotechnology-based Drug Delivery Industry Drivers
  3. 2.3 Nanotechnology-based Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Nanotechnology-based Drug Delivery Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nanotechnology-based Drug Delivery Revenue by Company (2021-2026)
  2. 3.2 Global Nanotechnology-based Drug Delivery Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nanotechnology-based Drug Delivery Key Company Head office and Area Served
  4. 3.4 Global Nanotechnology-based Drug Delivery Company, Product Type & Application
  5. 3.5 Global Nanotechnology-based Drug Delivery Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nanotechnology-based Drug Delivery Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nanotechnology-based Drug Delivery Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nanotechnology-based Drug Delivery Tier 1, Tier 2, and Tier 3
4 Nanotechnology-based Drug Delivery Market by Type
  1. 4.1 Global Nanotechnology-based Drug Delivery Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nanotechnology-based Drug Delivery Market Size by Type (2021-2032)
  3. 4.3 Global Nanotechnology-based Drug Delivery Market Size Share by Type (2021-2032)
5 Nanotechnology-based Drug Delivery Market by Application
  1. 5.1 Global Nanotechnology-based Drug Delivery Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nanotechnology-based Drug Delivery Market Size by Application (2021-2032)
  3. 5.3 Global Nanotechnology-based Drug Delivery Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AbbVie Inc.
  2. 6.1.1 AbbVie Inc. Company Information
  3. 6.1.2 AbbVie Inc. Business Overview
  4. 6.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Product Portfolio
  6. 6.1.5 AbbVie Inc. Recent Developments
  7. 6.2 BlueWillow Biologics Inc.
  8. 6.2.1 BlueWillow Biologics Inc. Company Information
  9. 6.2.2 BlueWillow Biologics Inc. Business Overview
  10. 6.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product Portfolio
  12. 6.2.5 BlueWillow Biologics Inc. Recent Developments
  13. 6.3 Camurus AB
  14. 6.3.1 Camurus AB Company Information
  15. 6.3.2 Camurus AB Business Overview
  16. 6.3.3 Camurus AB Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Camurus AB Nanotechnology-based Drug Delivery Product Portfolio
  18. 6.3.5 Camurus AB Recent Developments
  19. 6.4 Celgene, lnc.
  20. 6.4.1 Celgene, lnc. Company Information
  21. 6.4.2 Celgene, lnc. Business Overview
  22. 6.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Product Portfolio
  24. 6.4.5 Celgene, lnc. Recent Developments
  25. 6.5 Cristal Therapeutics
  26. 6.5.1 Cristal Therapeutics Company Information
  27. 6.5.2 Cristal Therapeutics Business Overview
  28. 6.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Product Portfolio
  30. 6.5.5 Cristal Therapeutics Recent Developments
  31. 6.6 EyePoint Pharmaceuticals
  32. 6.6.1 EyePoint Pharmaceuticals Company Information
  33. 6.6.2 EyePoint Pharmaceuticals Business Overview
  34. 6.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product Portfolio
  36. 6.6.5 EyePoint Pharmaceuticals Recent Developments
  37. 6.7 Johnson and Johnson
  38. 6.7.1 Johnson and Johnson Company Information
  39. 6.7.2 Johnson and Johnson Business Overview
  40. 6.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Product Portfolio
  42. 6.7.5 Johnson and Johnson Recent Developments
7 North America
  1. 7.1 North America Nanotechnology-based Drug Delivery Market Size (2021-2032)
  2. 7.2 North America Nanotechnology-based Drug Delivery Market Size by Type
  3. 7.2.1 North America Nanotechnology-based Drug Delivery Market Size by Type (2021-2026)
  4. 7.2.2 North America Nanotechnology-based Drug Delivery Market Size by Type (2027-2032)
  5. 7.2.3 North America Nanotechnology-based Drug Delivery Market Share by Type (2021-2032)
  6. 7.3 North America Nanotechnology-based Drug Delivery Market Size by Application
  7. 7.3.1 North America Nanotechnology-based Drug Delivery Market Size by Application (2021-2026)
  8. 7.3.2 North America Nanotechnology-based Drug Delivery Market Size by Application (2027-2032)
  9. 7.3.3 North America Nanotechnology-based Drug Delivery Market Share by Application (2021-2032)
  10. 7.4 North America Nanotechnology-based Drug Delivery Market Size by Country
  11. 7.4.1 North America Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
  13. 7.4.3 North America Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
  14. 7.4.4 North America Nanotechnology-based Drug Delivery Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nanotechnology-based Drug Delivery Market Size (2021-2032)
  2. 8.2 Europe Nanotechnology-based Drug Delivery Market Size by Type
  3. 8.2.1 Europe Nanotechnology-based Drug Delivery Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nanotechnology-based Drug Delivery Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nanotechnology-based Drug Delivery Market Share by Type (2021-2032)
  6. 8.3 Europe Nanotechnology-based Drug Delivery Market Size by Application
  7. 8.3.1 Europe Nanotechnology-based Drug Delivery Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nanotechnology-based Drug Delivery Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nanotechnology-based Drug Delivery Market Share by Application (2021-2032)
  10. 8.4 Europe Nanotechnology-based Drug Delivery Market Size by Country
  11. 8.4.1 Europe Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nanotechnology-based Drug Delivery Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nanotechnology-based Drug Delivery Market Size (2021-2032)
  2. 9.2 China Nanotechnology-based Drug Delivery Market Size by Type
  3. 9.2.1 China Nanotechnology-based Drug Delivery Market Size by Type (2021-2026)
  4. 9.2.2 China Nanotechnology-based Drug Delivery Market Size by Type (2027-2032)
  5. 9.2.3 China Nanotechnology-based Drug Delivery Market Share by Type (2021-2032)
  6. 9.3 China Nanotechnology-based Drug Delivery Market Size by Application
  7. 9.3.1 China Nanotechnology-based Drug Delivery Market Size by Application (2021-2026)
  8. 9.3.2 China Nanotechnology-based Drug Delivery Market Size by Application (2027-2032)
  9. 9.3.3 China Nanotechnology-based Drug Delivery Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nanotechnology-based Drug Delivery Market Size (2021-2032)
  2. 10.2 Asia Nanotechnology-based Drug Delivery Market Size by Type
  3. 10.2.1 Asia Nanotechnology-based Drug Delivery Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nanotechnology-based Drug Delivery Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nanotechnology-based Drug Delivery Market Share by Type (2021-2032)
  6. 10.3 Asia Nanotechnology-based Drug Delivery Market Size by Application
  7. 10.3.1 Asia Nanotechnology-based Drug Delivery Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nanotechnology-based Drug Delivery Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nanotechnology-based Drug Delivery Market Share by Application (2021-2032)
  10. 10.4 Asia Nanotechnology-based Drug Delivery Market Size by Country
  11. 10.4.1 Asia Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nanotechnology-based Drug Delivery Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nanotechnology-based Drug Delivery Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst